Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Impact of an Infusion Therapy Nursing Expert Service on Length of Stay and Clinical Results of Venous Access Devices (ETI)

This study has been completed.
Sponsor:
Collaborator:
KRONIKGUNE Cronicity Research Centre
Information provided by (Responsible Party):
Lucia Garate Echenique, Basque Health Service
ClinicalTrials.gov Identifier:
NCT01548365
First received: March 5, 2012
Last updated: September 20, 2013
Last verified: September 2013

March 5, 2012
September 20, 2013
March 2012
September 2012   (final data collection date for primary outcome measure)
Hospital Length of Stay [ Time Frame: 3 months ] [ Designated as safety issue: Yes ]
Same as current
Complete list of historical versions of study NCT01548365 on ClinicalTrials.gov Archive Site
  • Venous Access Devices reaching end of treatment [ Time Frame: 3 months ] [ Designated as safety issue: Yes ]
  • Incidence of complications derived from VAD [ Time Frame: 3 months ] [ Designated as safety issue: Yes ]
  • Patients receiving intravenous therapy at home [ Time Frame: 3 months ] [ Designated as safety issue: Yes ]
  • Patient satisfaction with VAD [ Time Frame: 3 months ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Impact of an Infusion Therapy Nursing Expert Service on Length of Stay and Clinical Results of Venous Access Devices
Impact of an Infusion Therapy Nursing Expert Service on Length of Stay, Clinical Results of Venous Access Devices and Satisfaction on Patients With Long Intravenous Therapy Prescription.

The purpose of this study is to determine whether an infusion therapy nursing expert service is effective in decreasing hospital length of stay, improving the clinical results of venous access devices and increasing patient satisfaction with venous access.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Health Services Research
Patients With Prolonged Intravenous Therapy
Other: Infusion therapy nursing expert service

The ITNE will assess the patient and treatment characteristics and use an evidence based decision making algorithm for the selection of the most suitable VAD.

If the VAD needed is a PICC or a midline ITNE will place it following hospital's protocols. If needed, ITNE will also educate and support patients and next of keens in the maintenance of the device at home.

If other devices such as peripheral catheters, central venous catheters (jugular or subclavian) or venous subcutaneous reservoirs are the preferable VADs for patients and treatment conditions, ITNE will work together with health professionals in charge of patients to activate the usual procedures to place the according device.

  • No Intervention: Control Group
    routine care for the selection, placement and maintenance of venous access devices (VAD).
  • Experimental: Infusion Therapy Nursing Expert
    Patients in this group will receive the infusion therapy nursing expert (ITNE) service.
    Intervention: Other: Infusion therapy nursing expert service
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
82
December 2012
September 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Require an estimated long prescription of intravenous treatment. These treatments may be of fluid therapy, pharmacological, nutritional or hemotherapy.

    • Estimation of 7 days or more of continuous intravenous therapy.
    • Estimation of an intermittent intravenous therapy of less than a week, but on a monthly basis or less and a total estimated duration superior to 3 months.
  • Be patient at Araba University Hospital

Exclusion Criteria:

  • To have a central venous catheter indwelled
  • MRSA (Methicillin Resistant Staphylococcus Aureus)
  • Younger than 18 years old
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Spain
 
NCT01548365
ITNE01
No
Lucia Garate Echenique, Basque Health Service
Basque Health Service
KRONIKGUNE Cronicity Research Centre
Principal Investigator: Lucia Garate, MsC Basque Health Service
Basque Health Service
September 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP